Friday , October 20 2017
Home / Resources / Videos / ADA 2017 (page 15)

ADA 2017

Exclusive: Dr Bruce Neal Discusses Canagliflozin’s Potential for Heart Failure Prevention

neal2

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have an exclusive interview from ADA 2017. The CANVAS study’s outcomes were “a positive first step” in proving that canagliflozin can be used for the primary prevention of heart failure in patients with diabetes, but more evidence is needed, according to the study’s lead author, Dr. Bruce Neal.

Read More »